BioFocus DPI announced today that it has signed a three year compound management agreement with Procter & Gamble Co. (P&G). Under the agreement, BioFocus DPI will manage P&G’s chemical library collection. These services will be provided by BioFocus DPI’s compound management facility in South San Francisco, USA.
“We are pleased to welcome Procter & Gamble as a new client to our compound management services, joining other prestigious names such as the National Institutes of Health,” said Scott Snyder, BioFocus DPI’s Senior Director, Compound Management. “This collaboration leverages our full suite of compound services and further expands our client base.”
About BioFocus DPI compound management
BioFocus DPI provides compound management services at its South San Francisco (USA) site, home to the National Institutes of Health Molecular Libraries Small Molecule Repository. BioFocus DPI offers the following compound management services: compound identification, selection, sourcing, analysis, storage, plating and reformatting, purification, and distribution. It employs state of the art equipment and compound handling techniques to ensure sample integrity. Customers include the government institutes NIH and Environmental Protection Agency as well as a number of biotech and pharmaceutical companies.
About BioFocus DPI
BioFocus DPI aims to expand its partners’ drug pipelines by accelerating the gene-to-drug candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services. As the service division of Galapagos, BioFocus DPI has over 250 employees in four countries worldwide.
For further information please visit www.biofocusdpi.com